| In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration K Suzuki, Y Tsunekawa, R Hernandez-Benitez, J Wu, J Zhu, EJ Kim, ... Nature 540 (7631), 144-149, 2016 | 1227 | 2016 |
| In vivo amelioration of age-associated hallmarks by partial reprogramming A Ocampo, P Reddy, P Martinez-Redondo, A Platero-Luengo, F Hatanaka, ... Cell 167 (7), 1719-1733. e12, 2016 | 805 | 2016 |
| A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging W Zhang, J Li, K Suzuki, J Qu, P Wang, J Zhou, X Liu, R Ren, X Xu, ... Science 348 (6239), 1160-1163, 2015 | 542 | 2015 |
| Endosomal escape and delivery of CRISPR/Cas9 genome editing machinery enabled by nanoscale zeolitic imidazolate framework SK Alsaiari, S Patil, M Alyami, KO Alamoudi, FA Aleisa, JS Merzaban, M Li, ... Journal of the American Chemical Society 140 (1), 143-146, 2018 | 445 | 2018 |
| Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells HK Liao, Y Gu, A Diaz, J Marlett, Y Takahashi, M Li, K Suzuki, R Xu, ... Nature communications 6 (1), 6413, 2015 | 415 | 2015 |
| Progressive degeneration of human neural stem cells caused by pathogenic LRRK2 GH Liu, J Qu, K Suzuki, E Nivet, M Li, N Montserrat, F Yi, X Xu, S Ruiz, ... Nature 491 (7425), 603-607, 2012 | 404 | 2012 |
| Organoids-Preclinical Models of Human Disease.Reply. JCIB M Li The New England journal of medicine 380 (20), 1981, 2019 | 305* | 2019 |
| Organoids—Preclinical Models of Human Disease M Li, JC Izpisua Belmonte New England Journal of Medicine 380 (6), 569-579, 2019 | 303 | 2019 |
| An alternative pluripotent state confers interspecies chimaeric competency J Wu, D Okamura, M Li, K Suzuki, C Luo, L Ma, Y He, Z Li, C Benner, ... Nature 521 (7552), 316-321, 2015 | 265 | 2015 |
| Targeted Gene Correction of Laminopathy-Associated LMNA Mutations in Patient-Specific iPSCs GH Liu, K Suzuki, J Qu, I Sancho-Martinez, F Yi, M Li, S Kumar, E Nivet, ... Cell stem cell 8 (6), 688-694, 2011 | 264 | 2011 |
| Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones K Suzuki, C Yu, J Qu, M Li, X Yao, T Yuan, A Goebl, S Tang, R Ren, ... Cell stem cell 15 (1), 31-36, 2014 | 202 | 2014 |
| Conversion of human fibroblasts to angioblast-like progenitor cells L Kurian, I Sancho-Martinez, E Nivet, A Aguirre, K Moon, C Pendaries, ... Nature methods 10 (1), 77-83, 2013 | 194 | 2013 |
| Ground rules of the pluripotency gene regulatory network M Li, JCI Belmonte Nature Reviews Genetics 18 (3), 180-191, 2017 | 182 | 2017 |
| 3D culture supports long-term expansion of mouse and human nephrogenic progenitors Z Li, T Araoka, J Wu, HK Liao, M Li, M Lazo, B Zhou, Y Sui, MZ Wu, ... Cell stem cell 19 (4), 516-529, 2016 | 180 | 2016 |
| A cut above the rest: targeted genome editing technologies in human pluripotent stem cells M Li, K Suzuki, NY Kim, GH Liu, JCI Belmonte Journal of Biological Chemistry 289 (8), 4594-4599, 2014 | 165 | 2014 |
| Autophagic control of cell ‘stemness’ H Pan, N Cai, M Li, GH Liu, JC Izpisua Belmonte EMBO molecular medicine 5 (3), 327-331, 2013 | 165 | 2013 |
| Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs GH Liu, K Suzuki, M Li, J Qu, N Montserrat, C Tarantino, Y Gu, F Yi, X Xu, ... Nature communications 5 (1), 4330, 2014 | 136 | 2014 |
| Navigating the epigenetic landscape of pluripotent stem cells M Li, GH Liu, JCI Belmonte Nature reviews Molecular cell biology 13 (8), 524-535, 2012 | 136 | 2012 |
| Deconstructing the pluripotency gene regulatory network M Li, JC Izpisua Belmonte Nature cell biology 20 (4), 382-392, 2018 | 115 | 2018 |
| DeepSimulator: a deep simulator for Nanopore sequencing Y Li, R Han, C Bi, M Li, S Wang, X Gao Bioinformatics 34 (17), 2899-2908, 2018 | 110 | 2018 |
Juan Carlos Izpisua BelmonteSalk Institute for Biological StudiesVerified email at salk.edu
